Opus Genetics, Inc. (IRD) Operating cash flow 2016–2025
Opus Genetics, Inc. (IRD) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$35.3MFY2025 · since FY2016: -$13.2M → -$35.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$35.3M | -37.8% |
| FY2024 | -$25.6M | -2200.0% |
| FY2023 | -$1.1M | -107.8% |
| FY2022 | $14.3M | +173.9% |
| FY2021 | -$19.4M | -185.0% |
| FY2020 | -$6.8M | -89.2% |
| FY2019 | -$3.6M | +80.9% |
| FY2018 | -$18.8M | -22.2% |
| FY2017 | -$15.4M | -16.6% |
| FY2016 | -$13.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice